Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment.

MLA

du Plessis, Stefan, et al. “Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment.” Schizophrenia Bulletin, vol. 49, no. 4, July 2023, pp. 1067–77. EBSCOhost, https://doi.org/10.1093/schbul/sbad040.

APA

du Plessis, S., Chand, G. B., Erus, G., Phahladira, L., Luckhoff, H. K., Smit, R., Asmal, L., Wolf, D. H., Davatzikos, C., & Emsley, R. (2023). Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment. Schizophrenia Bulletin, 49(4), 1067–1077. https://doi.org/10.1093/schbul/sbad040

Chicago

du Plessis, Stefan, Ganesh B Chand, Guray Erus, Lebogang Phahladira, Hilmar K Luckhoff, Retha Smit, Laila Asmal, Daniel H Wolf, Christos Davatzikos, and Robin Emsley. 2023. “Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment.” Schizophrenia Bulletin 49 (4): 1067–77. doi:10.1093/schbul/sbad040.